BioWorld

April 7, 2003

Administration Won't Reimburse Failed Project BioShield Drugs

Senior Bush administration officials said companies contracted to develop biomedical countermeasures under Project BioShield would not receive full government payment until the FDA approved their products. (BioWorld Today) Read More

For Biotech, Speaker Declares: 'I've Never Seen A Better Time'

Palindromic DNA Sequence Allows p53 Target Genes To Kill Off Cancer Cells & Suppress Tumor Formation

Deltagen Gains At Least $10M In Private Financing Commitment

Correction

Memantine Improves Cognition When Combined With Aricept

Affymetrix Stock Falls Fast As It Projects Lower Product Revenue

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 29, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for April 28, 2026

Chinese biotechs gain leverage as partners in dealmaking

BioWorld

China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...

Plasticity, properly parsed, provides psychiatric platform

BioWorld

If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...

Roche identifies new TREM2 agonists

BioWorld Science

F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...